Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A5 | Q86YT5 | 3/20 | 0.50 |
| ▸ | KDM1A | O60341 | 5/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6588356 | 0.86 | SLC13A5 (0.49) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL12093550 | 0.84 | SLC13A5 (0.51) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL8116304 | 0.83 | BTK (0.49) | SLC13A5KDM1AMAOAMAOBBTK | |
| SCHEMBL12948866 | 0.83 | SLC13A5 (0.52) | SLC13A5L3MBTL1NPC1SSTR4 | |
| SCHEMBL27585504 | 0.82 | KDM1A (0.41) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL18291875 | 0.82 | SLC13A5 (0.49) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL2960548 | 0.82 | SLC13A5 (0.49) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL129593 | 0.82 | KDM1A (0.46) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL19465 | 0.82 | HTR2A (0.46) | SLC13A5KDM1AMAOAMAOBAPLNR | |
| SCHEMBL31365171 | 0.82 | MEN1 (0.60) | SLC13A5KDM1AMAOAMAOBAPLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116854626-A | Preparation method of 2-vinyl pyridine | 河南省科学院高新技术研究中心 | 2023-10-10 | — | — | CN | claimed |
| CN-116854626-B | Preparation method of 2-vinyl pyridine | 河南省科学院高新技术研究中心 | 2025-10-28 | — | — | CN | disclosed |
| CN-119977873-A | Method for synthesizing 2-vinyl pyridine by one-pot method | 南京红太阳生物化学有限责任公司 | 2025-05-13 | — | — | CN | disclosed |
| US-20240018115-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | LOXO ONCOLOGY, INC. | 2024-01-18 | — | — | US | disclosed |
| CN-116854626-A | Preparation method of 2-vinyl pyridine | 河南省科学院高新技术研究中心 | 2023-10-10 | — | — | CN | disclosed |
| CN-116854626-A | Preparation method of 2-vinyl pyridine | 河南省科学院高新技术研究中心 | 2023-10-10 | — | — | CN | disclosed |
| US-11771738-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ABM THERAPEUTICS CORP (US) | 2023-09-28 | — | — | US | disclosed |
| US-11753393-B2 | Dihydroorotate dehydrogenase inhibitors | JANSSEN BIOTECH, INC. | 2023-09-12 | — | — | US | disclosed |
| US-11739077-B2 | Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof | INSILICO MEDICINE IP LIMITED (HK) | 2023-08-29 | — | — | US | disclosed |
| US-7514452-B2 | 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same | DAINIPPON PHARMACEUTICAL CO., LTD (JP) | 2009-04-07 | — | — | US | disclosed |
| US-20090054423-A1 | Niacin receptor agonists, compositions containing such compounds and methods of treatment | MERCK SHARP & DOHME CORP. | 2009-02-26 | — | — | US | disclosed |
| US-20080312435-A1 | Imine Compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080280925-A1 | Amines as Small Molecule Inhibitors | METHYLGENE INC. | 2008-11-13 | — | — | US | disclosed |
| US-20080132503-A1 | Inhibitors of Histone Deacetylase | METHYLGENE INC. (CA) | 2008-06-05 | — | — | US | disclosed |
| WO-2008008374-A2 | CCR2 INHIBITORS AND METHODS OF USE THEREOF | CHEMOCENTRYX, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20080004282-A1 | Compositions and methods for modulating gated ion channels | PAINCEPTOR PHARMA CORPORATION (CA) | 2008-01-03 | — | — | US | disclosed |
| US-20070264196-A1 | Modulators of ATP-binding cassette transporters | VERTEX PHARMACEUTICALS INCORPORATED | 2007-11-15 | — | — | US | disclosed |
| US-20070225365-A1 | Cetp Inhibitors | MERCK & CO., INC. (US) | 2007-09-27 | — | — | US | disclosed |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | MERCK SHARP & DOHME CORP. | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ERBB2, ERBB3, ERBB4 | SLC13A5 4851/4885KDM1A 1993/4885MAOA 2096/4885 |
| US-20080312435-A1 | Imine Compound | CNR1, CNR2, HRH4 | SLC13A5 3061/4885KDM1A 2503/4885MAOA 2501/4885 |
| US-20080280925-A1 | Amines as Small Molecule Inhibitors | CARM1, PRMT1, PRMT3 | SLC13A5 2407/4885KDM1A 105/4885MAOA 569/4885 |
| US-11753393-B2 | Dihydroorotate dehydrogenase inhibitors | DHODH, DLD, DPYD | SLC13A5 1694/4885KDM1A 1067/4885MAOA 368/4885 |
| US-20070225365-A1 | Cetp Inhibitors | CETP, APOB, NPC1 | SLC13A5 2589/4885KDM1A 1488/4885MAOA 1565/4885 |
| US-20240018115-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | PIK3CA, PIK3R4, PIK3R5 | SLC13A5 3294/4885KDM1A 3056/4885MAOA 2964/4885 |
| US-20070264196-A1 | Modulators of ATP-binding cassette transporters | CFTR, ABCB1, ABCC2 | SLC13A5 641/4885KDM1A 4611/4885MAOA 3866/4885 |
| US-20080004282-A1 | Compositions and methods for modulating gated ion channels | KCNN3, KCNN2, HCN3 | SLC13A5 990/4885KDM1A 3078/4885MAOA 1975/4885 |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | GRM5, GRIK5, GRM1 | SLC13A5 2769/4885KDM1A 722/4885MAOA 3224/4885 |
| US-11771738-B2 | Endoparasitic depsipeptides | VIP, PREP, VIPR1 | SLC13A5 1616/4885KDM1A 2133/4885MAOA 4400/4885 |
| US-20090054423-A1 | Niacin receptor agonists, compositions containing such compounds and methods of treatment | FFAR1, HCAR1, GPR119 | SLC13A5 257/4885KDM1A 4370/4885MAOA 860/4885 |
| US-20080132503-A1 | Inhibitors of Histone Deacetylase | HDAC1, HDAC5, HDAC3 | SLC13A5 4575/4885KDM1A 41/4885MAOA 1961/4885 |
| US-11739077-B2 | Small molecule inhibitors of ubiquitin specific protease 1 (USP1) and uses thereof | USP1, USP2, USP28 | SLC13A5 4751/4885KDM1A 205/4885MAOA 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.